Inositol Dosage: How Much to Take (Evidence-Based)

What Is Inositol and Why Does Dosage Matter?

Inositol is a naturally occurring sugar alcohol found in cell membranes, where it acts as a second messenger in insulin and hormonal signalling pathways. The two forms most used as supplements are myo-inositol (MI) and D-chiro-inositol (DCI). Getting the inositol dosage right matters because the two forms have distinct physiological roles, and combining them in the wrong ratio — or using too little — produces little benefit.

OstroVit Inositol 200g Naturaalne is one of the inositol supplements available at maxfit.ee for those looking to incorporate this compound into their routine.

Studied Effective Dose Ranges

Myo-Inositol for PCOS and Insulin Sensitivity

The most robust clinical data comes from polycystic ovary syndrome (PCOS) research. A randomised controlled trial by Unfer et al. (2012) found that a myo-inositol dose of 4 g per day combined with folic acid significantly improved insulin sensitivity and menstrual regularity compared to placebo over 14 weeks. Most studies in this area use doses in the 2–4 g range for myo-inositol. (Unfer et al., 2012)

Combined MI:DCI Ratio

The physiological ratio of myo-inositol to D-chiro-inositol in human plasma is approximately 40:1. A clinical study by Nordio & Proietti (2012) found that combined supplementation with myo-inositol and D-chiro-inositol at a combined dose produced favourable hormonal outcomes in PCOS patients, suggesting the ratio matters as much as the absolute dose. (Nordio & Proietti, 2012)

Dose by Goal

For mental health applications at very high doses (12–18 g), clinical supervision is essential — these doses are studied in controlled settings, not as general supplementation. For everyday wellness, the 2–4 g daily range covers most goals.

Timing Relative to Dose

For insulin and hormonal effects, splitting the dose — taking half in the morning and half in the evening with food — appears to be the approach used in most successful PCOS trials. For sleep or relaxation purposes, a single dose taken 30–60 minutes before bed is the common protocol.

Inositol is water-soluble, so food co-ingestion does not significantly affect absorption, though taking it with a meal can improve tolerability for those who experience mild digestive discomfort.

Upper Limits and Safety

At doses used in most wellness supplementation (up to 4 g/day), inositol is very well tolerated. At higher doses (12 g or more), some individuals report loose stools, nausea, or mild gastrointestinal discomfort. European food safety authorities note that myo-inositol at typical supplemental doses has a well-characterised safety profile, and no formal tolerable upper intake level has been established for general use because adverse effects emerge only at very high doses.

Practical Protocol

1. Start low: begin with 1–2 g myo-inositol daily and assess tolerance for 1–2 weeks.
2. Build to target: most PCOS and insulin-sensitivity studies use 4 g/day in two divided doses.
3. Consider the ratio: if using a combined formula, look for a 40:1 MI:DCI ratio.
4. Be consistent: inositol's hormonal effects take time — most trials run for at least 12–14 weeks.
5. Consult a healthcare provider if you are managing a diagnosed condition such as PCOS.

FAQ

How long does it take for inositol to work?

For hormonal and metabolic effects, most clinical trials show measurable changes after 12–16 weeks of consistent daily use. Sleep-related effects may be noticed sooner, within 1–2 weeks, though evidence here is more limited.

Can I take too much inositol?

At supplemental doses up to 4 g/day, side effects are uncommon. High doses (above 12 g/day) studied for specific conditions may cause gastrointestinal symptoms in some individuals. Always start at the lower end of the range.

Should men take inositol?

Most inositol research has focused on female reproductive health, but myo-inositol is a universal cellular signalling molecule. Some research explores its role in sperm quality and male fertility; evidence is emerging but smaller in volume compared to PCOS research.

References

Unfer, V., Carlomagno, G., Dante, G., & Facchinetti, F. (2012). Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials. Gynecological Endocrinology, 28(7), 509–515. https://pubmed.ncbi.nlm.nih.gov/22296306/

Nordio, M., & Proietti, E. (2012). The combined therapy with myo-inositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone. European Review for Medical and Pharmacological Sciences, 16(5), 575–581. https://pubmed.ncbi.nlm.nih.gov/22778524/